Fengfeng Guo
Sir Run Run Shaw Hospital
Hangzhou, 310009, China
Hangzhou, 310009, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
1-Deoxynojirimycin promotes cardiac function and rescues mitochondrial cristae in mitochondrial hypertrophic cardiomyopathy.
Journal: The Journal of clinical investigation
Published: August 19, 2022
Overexpression of KCNJ2 enhances maturation of human-induced pluripotent stem cell-derived cardiomyocytes.
Journal: Stem cell research & therapy
Published: August 11, 2022
Generation of an induced pluripotent stem cell line (ZJULLi003-A) from a hypertrophic cardiomyopathy patient carrying MYH7/c.4384G > A mutation.
Journal: Stem cell research
Published: June 30, 2022
Human induced pluripotent stem cell-derived cardiomyocytes reveal abnormal TGFβ signaling in type 2 diabetes mellitus.
Journal: Journal of molecular and cellular cardiology
Published: October 28, 2019
Patient-Specific and Gene-Corrected Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Short QT Syndrome.
Journal: Circulation research
Published: December 25, 2018
Inhibition of TRPC1 prevents cardiac hypertrophy via NF-κB signaling pathway in human pluripotent stem cell-derived cardiomyocytes.
Journal: Journal of molecular and cellular cardiology
Published: June 25, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026